beta-Alanine
Concept
Vocabulary Service
Overview
subject area of
-
2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation Academic Article
-
A Benefit-Risk Assessment of Dabigatran in the Prevention of Venous Thromboembolism in Orthopaedic Surgery Academic Article
-
Activated prothrombin complex concentrate for dabigatran-associated bleeding Academic Article
-
Acute management of bleeding in patients on novel oral anticoagulants Academic Article
-
Additional Events in the RE-LY Trial Academic Article
-
Adherence to anticoagulant treatment with dabigatran in a real-world setting Academic Article
-
Advances in treatment and management Academic Article
-
Advantages and limitations of the new anticoagulants Academic Article
-
Analysis of Upper Gastrointestinal Adverse Events Among Patients Given Dabigatran in the RE-LY Trial Academic Article
-
Anticoagulation for the initial treatment of venous thromboembolism in people with cancer Academic Article
-
Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer Academic Article
-
Antithrombotic Therapy for Atrial Fibrillation Academic Article
-
Approach to the new oral anticoagulants in family practice: part 1: comparing the options. Academic Article
-
Approach to the new oral anticoagulants in family practice: part 2: addressing frequently asked questions. Academic Article
-
Assessing the impact of dabigatran and warfarin on health-related quality of life: Results from an RE-LY sub-study Academic Article
-
Balancing the Benefits and Risks of 2 Doses of Dabigatran Compared With Warfarin in Atrial Fibrillation Academic Article
-
Bleeding and antidotes in new oral anticoagulants Academic Article
-
Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter Academic Article
-
Carnosine, taurine and enzyme activities of human skeletal muscle fibres from elderly subjects with osteoarthritis and young moderately active subjects Academic Article
-
Causes of Death and Influencing Factors in Patients With Atrial Fibrillation Academic Article
-
Clinical review: Clinical management of new oral anticoagulants: a structured review with emphasis on the reversal of bleeding complications Academic Article
-
Cost-effectiveness of Dabigatran and Rivaroxaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation Academic Article
-
Dabigatran Versus Warfarin in Patients With Atrial Fibrillation Academic Article
-
Dabigatran and risk of myocardial infarction Academic Article
-
Dabigatran as anticoagulant therapy for atrial fibrillation. Which patients should receive it, which patients may not need it, and other practical aspects of patient management Academic Article
-
Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction? Academic Article
-
Dabigatran compared with warfarin in patients with atrial fibrillation and symptomatic heart failure: a subgroup analysis of the RE-LY trial Academic Article
-
Dabigatran efficacy-safety assessment for stroke prevention in patients with atrial fibrillation Academic Article
-
Dabigatran for patients with a mechanical valve Academic Article
-
Dabigatran in Patients with Mechanical Heart Valves Academic Article
-
Dabigatran monitoring made simple? Academic Article
-
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves Academic Article
-
Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada Academic Article
-
Dabigatran versus warfarin in patients with mechanical heart valves: reply Academic Article
-
Dabigatran-Induced Acute Hepatitis Academic Article
-
Dabigatran-related coagulopathy: when can we assume the effect has “worn off”? Academic Article
-
Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation Academic Article
-
Efficacy and Safety of Dabigatran Compared to Warfarin in Patients With Paroxysmal, Persistent, and Permanent Atrial Fibrillation Academic Article
-
Efficacy and Safety of Dabigatran vs. Warfarin in Patients With Atrial Fibrillation - Sub-Analysis in Japanese Population in RE-LY Trial - Academic Article
-
Enoxaparin Versus Dabigatran or Rivaroxaban for Thromboprophylaxis After Hip or Knee Arthroplasty Academic Article
-
Evolving use of new oral anticoagulants for treatment of venous thromboembolism Academic Article
-
Extended Anticoagulation in Venous Thromboembolism Academic Article
-
Extended Use of Dabigatran, Warfarin, or Placebo in Venous Thromboembolism Academic Article
-
Extended anticoagulation in venous thromboembolism. Academic Article
-
Extended anticoagulation in venous thromboembolism. Academic Article
-
Extended anticoagulation in venous thromboembolism. Academic Article
-
Gastrointestinal bleeding with the new oral anticoagulants – defining the issues and the management strategies Academic Article
-
Home-monitoring of oral anticoagulation vs. dabigatran Academic Article
-
How I treat target-specific oral anticoagulant–associated bleeding Academic Article
-
Idarucizumab for Dabigatran Reversal Academic Article
-
Intensity and Quality of Warfarin Anticoagulation in Chinese Patients Academic Article
-
Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran Academic Article
-
Is there a role for the novel oral anticoagulants in patients with an acute coronary syndrome? A review of the clinical trials Academic Article
-
Is there really misuse and abuse of dabigatran? Academic Article
-
Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants Academic Article
-
Letter by Van de Werf et al Regarding Article, “Using Dabigatran in Patients With Stroke: A Practical Guide for Clinicians” Academic Article
-
Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin Academic Article
-
Management consensus guidance for the use of rivaroxaban – an oral, direct factor Xa inhibitor Academic Article
-
Management of Anticoagulation Around Pacemaker and Defibrillator Surgery Academic Article
-
Managing New Oral Anticoagulants in the Perioperative and Intensive Care Unit Setting Academic Article
-
More on Acutely Injured Patients Receiving Dabigatran Academic Article
-
Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial Academic Article
-
New anticoagulants in atrial fibrillation management Conference Paper
-
New oral anticoagulant agents – general features and outcomes in subsets of patients Academic Article
-
New oral anticoagulants and oculoplastic surgery Academic Article
-
New oral anticoagulants for stroke prevention in atrial fibrillation: impact of study design, double counting and unexpected findings on interpretation of study results and conclusions Academic Article
-
New oral anticoagulants: which one should my patient use? Academic Article
-
Novel oral anticoagulants in secondary prevention of stroke Academic Article
-
Nutritional Strategies to Support Adaptation to High-Intensity Interval Training in Team Sports Academic Article
-
Only high levels of dabigatran attenuate catheter thrombosis in vitro and in rabbits Academic Article
-
Overview of the New Oral Anticoagulants Academic Article
-
Patient outcomes using the European label for dabigatran Academic Article
-
Perioperative Management of Dabigatran Academic Article
-
Perioperative management of patients who are receiving a novel oral anticoagulant Academic Article
-
Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin Academic Article
-
Periprocedural Management and Approach to Bleeding in Patients Taking Dabigatran Academic Article
-
Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy Academic Article
-
Pharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatran Academic Article
-
Pharmacologic Properties of the New Oral Anticoagulants: A Clinician-oriented Review with a Focus on Perioperative Management Academic Article
-
Potential net clinical benefit of population-wide implementation of apixaban and dabigatran among European patients with atrial fibrillation Academic Article
-
Practical aspects of new oral anticoagulant use in atrial fibrillation Academic Article
-
Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban Academic Article
-
Preventing Cardioembolic Stroke in Atrial Fibrillation with Dabigatran Academic Article
-
Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding Academic Article
-
Response to Letter Regarding Article, “Causes of Death and Influencing Factors in Patients With Atrial Fibrillation: A Competing-Risk Analysis From the Randomized Evaluation of Long-Term Anticoagulant Therapy Study” Academic Article
-
Response to Letter Regarding Article, “Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) Trial Analysis” Academic Article
-
Response to Letter Regarding Article, “Management and Outcomes of Major Bleeding During Treatment With Dabigatran or Warfarin” Academic Article
-
Response to letters regarding article, “Periprocedural bleeding and thromboembolic events with dabigatran compared with warfarin: results from the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial”. Academic Article
-
Response. Academic Article
-
Risk Stratification and Stroke Prevention Therapy Care Gaps in Canadian Atrial Fibrillation Patients (from the Co-ordinated National Network to Engage Physicians in the Care and Treatment of Patients With Atrial Fibrillation Chart Audit) Academic Article
-
Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation Academic Article
-
Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS_2 Score: A Subgroup Analysis of the RE-LY Trial Academic Article
-
Safety and Efficacy of Dabigatran Compared With Warfarin for Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-analysis Academic Article
-
Stroke Prevention in Atrial Fibrillation Patients With Chronic Kidney Disease Academic Article
-
The Effects of Beta-Alanine Supplementation on Performance: A Systematic Review of the Literature Academic Article
-
The King is Dead (Warfarin): Direct Thrombin and Factor Xa Inhibitors: The Next Diadochian War? Academic Article
-
The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study Academic Article
-
The Oral Thrombin Inhibitor Dabigatran: Strengths and Weaknesses Academic Article
-
Transition from apixaban to warfarin—addressing excess stroke, systemic embolism, and major bleeding Academic Article
-
Treatment of Acute Venous Thromboembolism With Dabigatran or Warfarin and Pooled Analysis Academic Article
-
Treatment of venous thromboembolism with dabigatran Academic Article
-
Validation of a patient decision aid for choosing between dabigatran and warfarin for atrial fibrillation. Academic Article
-
Venous thromboembolism management: where do novel anticoagulants fit? Academic Article
-
Vitamin K antagonist-experienced patients with a history of stroke/transient ischaemic attack who switched from warfarin to dabigatran increased their rate of recurrent stroke/transient ischaemic attack compared with those on warfarin Academic Article
-
β-Alanine Supplementation Does Not Augment the Skeletal Muscle Adaptive Response to 6 Weeks of Sprint Interval Training Academic Article
-
γT-S195A thrombin reduces the anticoagulant effects of dabigatranin vitroandin vivo Academic Article